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Abstract 
The rate of gross conformational change of a,-macroglobulin (a,M) during its proteinase trapping was directly determined for the first time using 
time-resolved X-ray solution scattering. Decrease of radius of gyration was observed under pseudo-first-order conditions with excess proteinases, 
which exhibited a monophasic timecourse. The rate constants were 0.5 f 0.1 s-’ and 0.8 f 0.2 s-’ for the reaction with chymotrypsin and trypsin, 
respectively. There was no concentration dependence of the observed rate constants. Therefore, the rate-limiting step of the gross conformational 
change was not the bimolecular encounter eaction between a,M and proteinases, which requires a new proposal of pre-trapping of proteinases before 
the gross conformational change. 
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1. Introduction 
Human a,-macroglobulin (a,M) is a proteinase inhib- 
itor of M, 720,000 [l] present in plasma at a concentra- 
tion of about 3 mglml. The protein is composed of four 
identical subunits linked in pairs by disulfide bonds and 
capable of inhibiting two trypsin or chymotrypsin mole- 
cules with one a,M molecule. Unlike other proteinase 
inhibitors, a,M does not block the active site of the 
proteinase but rather engulfs the whole enzyme molecule 
by the ‘trap mechanism’, as first proposed by Barrett and 
Starkey [2]. According to this proposal, a proteinase 
binds to a particular sequence in a,M, named the ‘bait 
region’, and hydrolyzes a peptide bond therein. This 
causes a rapid conformational change that physically 
entraps the enzyme molecule within the a,M molecule. 
Thus, the proposed entrapping conformational change 
is the key to the proteinase inhibitory action of a,M. 
ing [8,9] showed that a large conformational change oc- 
curs when a,M traps proteinases. Such a conformational 
change was also detected by gel-electrophoresis [lo], sed- 
imentation analysis [ 1 l] and gel-chromatography [4]. Al- 
though fluorescence stopped-flow kinetic investigations 
were reported [ 12,131, the correspondence of the kinetics 
to the gross conformational change was not clear. 
Parameters obtainable from X-ray solution scattering 
are limited but a few physically unambiguous parameters 
are obtainable, including the radius of gyration (RJ, and 
its feasibility in the study of time-dependent conforma- 
tional change of bio-macromolecules i well established 
[14-191. Moreover, as X-ray is scattered by electrons, a 
change of X-ray scattering directly represents the change 
of molecular shape. Here we report the rates of the gross 
conformational changes of a,M induced by chymotryp- 
sin and trypsin as determined by time-resolved X-ray 
solution scattering. 
Electron microscopy [3-71 and X-ray solution scatter- 
2. Materials and methods 
* Corresponding authors. Fax: (81) (45) 923 0379. 
2. I. Proteins 
**Present address: Department of Liberal Arts, Kansai Medical Uni- 
versity, Uyama-Higashimachi, Hirakata, Osaka, 573, Japan. 
Human cr,M was purified from human plasma as described earlier 
[20] using polyethylene glycol precipitation, gel-chromatography and 
Zr?’ chelate chromatography. The final preparation was homogeneous 
by gel-electrophoretic criteria. 
Abbreviations: a,M, a,-macroglobulin; R,, radius of gyration, PMSF, 
phenylmethanesulfonyl fluoride. 
a-Chymotrypsin was purchased from Sigma Chemical Co. (St. Louis, 
MO). More than 95% of chymotrypsin molecules were active, as shown 
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by active site titration with p-nitrophenyl acetate as substrate [21]. 
Inactive chymotrypsin was prepared by incubating chymotrypsin with 
10 mM phenylmethanesulfonyl fluoride (PMSF) for 2 h at room tem- 
perature. Trypsin was purchased from Sigma Chemical Co. and the 
active molecule was purified through benzamidine-Sepharose (Pharma- 
cia LKB, Uppsala, Sweden). a,Mchymotrypsin complex and cc,M- 
trypsin complex were obtained by mixing a,M with chymotrypsin or 
trypsin in the molar ratio 1:2 (a,M:proteinase), followed by incubation 
at room temperature for 10 min. 
2.2. X-ray solution scattering 
X-ray solution scattering experiments were performed at the BL 
15-Al small-angle installation at the Photon Factory, Tsukuba, Japan. 
The mirror-monochromator camera gave an X-ray beam with a wave- 
length of 1.5 A and cross-section of 2.9 mm (horizontal) x 2.0 mm 
(vertical) at the sample level. Data were recorded by a linear position- 
sensitive detector with 512 channels placed at 2.3 m from the sample 
[22]. The stopped-flow apparatus had two N, gas pressure-driven syr- 
inges, and a mixer designed for viscous solution. The mixed solution 
entered the X-ray scattering cell equipped with two quartz windows (50 
gum thick), 1 mm apart from each other and with a 4 x 3 mm usable area. 
The mixing ratio (vol./vol.) was 1:l. The dead time of the device was 
estimated to be less than 10 ms [23]. The temperature of the apparatus 
was kept at 5°C with a Peltier cooling device. 
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Fig. 2. Guinier plot of ol,M (7.5 mg/ml). 
The radius of gyration, R,, was determined from the Guinier plot of 
scattering curve within the angular range 2.5 x lo-’ A-’ < s < 7.5 x 
1o-3 A-‘. 
3. Results 
Static X-ray small angle scattering patterns of CC,M 
before and after the reaction with chymotrypsin are 
shown in Fig. 1. When a,M reacted with chymotrypsin, 
the scattering intensity increased in the small angle re- 
gion and a side peak characteristic of intact a,M disap- 
peared. When a,M reacted with trypsin a similar change 
of scattering pattern was observed, as reported by &ter- 
berg and Malmensten [9]. 
The Guinier plot of the scattering pattern of a,M (Fig. 
2) showed linearity for a fairly wide range in the small 
angle region and the linear region was more extended 
after the reaction with proteinases, as shown in Fig. 3. 
The radius of gyration (R,), determined from the Guinier 
plot for 7.5 mg/ml a,M, changed from 7.9 IL 0.5 nm to 
6.8 f 0.5 nm when a,M reacted with chymotrypsin. 
To observe the timecourse of the conformational 
change of cx,M induced by the reaction with proteinases, 
a,M (typically 5 mg/ml) was mixed with an excess 
amount of chymotrypsin or trypsin in stopped-flow ap- 
paratus and X-ray solution scattering was measured. An 
example of calculated values of Rg2 for the reaction mix- 
ture of a,M and chymotrypsin were plotted against ime 
in Fig. 4. The data showed a good fit to an exponential 
curve with a rate constant of 0.54 s-‘. The estimated R, 
was 7.3 nm at time zero and 6.9 nm at the end point. 
When chymotrypsin was inactivated with PMSF and 
then mixed with a,M, the observed R, was constant at 
7.3 nm (+ 0.2 nm). Experiments were repeated with dif- 
ferent concentrations of a,M (10 mg/ml and 5.0 mg!ml 
at final) and the rate constant was confirmed to have no 
dependence on the concentration of a,M. Fig. 5 is an 
example of calculated values of Rg2 for the reaction mix- 
ture of a,M and trypsin. This data was fitted with an 
exponential curve with a rate constant of 0.89 SC’. 
As summarized in Table 1, concentration dependen- 
cies of the rate constants were examined for chymotryp- 
sin and trypsin to determine the order of the reaction. 
Although the concentrations of proteinases were 
changed by up to 10 times, no concentration dependency 
was observed. From this result, the rate-limiting step for 
the conformational change observed with X-ray solution 
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Fig. 1. X-ray solution scattering of a,M. Small angle X-ray scattering 
curves for solutions of a,M (7.5 mg/ml) before (- ) and after 
reaction with chymotrypsin (- - -). Counts I (s) are plotted against s, 
where: s = (2/a)sin 0, and 28 is the scattering angle. 
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Fig. 3. Guinier plot of a,M-chymotrypsin complex (7.5 mg/ml). 
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Table 1 
Rate constants of the gross conformational change 
0 2 I 6 8 
Time [secl 
Fig. 4. Plot of the calculated R,’ of &,M and chymotrypsin mixture as 
a function of time. a,M (10 mg/ml) was mixed, in a ratio of 1.O:l.O 
(vol.:vol.), with chymotrypsin (3.5 mg/ml). Both solutions were at 5.O”C 
in PBS. Each shot with a time-slice of 500 ms had a total volume of 180 
,~l, and 64 shots were accumulated. The solid curve is the fitting curve 
with a rate constant of 0.54 s-l. 
scattering was concluded to be the first order reaction for 
both chymotrypsin and trypsin. 
4. Discussion 
The observed Rg during the reaction was the apparent 
R, of the mixture of macroglobulins before and after the 
transformation. The apparent R, can be described as: 
R 2 = (1 - x)M,2R,2 + xM,2R, 
g (1 - x)M,2 + x&&2 
where x is the molar ratio of the altered form of mac- 
roglobulin; M, and R, are the molecular weight and 
radius of gyration of macroglobulin before the confor- 
mational change; M,, and R,, are the molecular weight 
and radius of gyration of the altered form of macroglob- 
ulin [24]. As the molecular weight of chymotrypsin or 
trypsin is about l/30 of that of macroglobulin, the differ- 
ence of M, and Mb is negligible. In this case the observed 
R, can be expressed as: 
Rg2 = (1 - x)Ra2 + xRb2 wfa = 6) 
Fig. 5. Plot of the calculated Rg* of @M and trypsin mixture as a 
function of time. cc,M (10 mg/ml) was mixed, in a ratio of 1.O:l.O 
(vol./vol.), with trypsin (3.2 mg/ml). Other experimental conditions 
were the same as in Fig. 4, and 66 shots were accumulated. The solid 
curve is the fitting curve with a rate constant of 0.89 s-r. 
Proteinase Concentration of proteinase @M) 
21 70 210 
Chymotrypsin 0.50” 
Trypsin 0.82” 
Values are t, (SC’). Concentrations of a,M were “2.0 PM, b7.0 PM. 
This allowed us to analyze the observed timecourse of 
Rg2 as an exponential curve and calculate the rate con- 
stant. Although the effect of free proteinase to the scat- 
tering profile was negligible, which we confirmed by 
measuring the scattering of the proteinase solution, the 
scatterings of proteinase were subtracted from all scat- 
terings of solutions containing proteinase. 
The conformational change detectable with X-ray so- 
lution scattering were actually observed within the time 
scale shown in Figs. 4 and 5. This was proved by the fact 
that the scattering patterns in the first frame of stopped- 
flow X-ray solution scattering were the same as those for 
intact macroglobulin, and the scattering patterns of the 
last frame of stoppedflow X-ray solution scattering were 
the same as those for macroglobulin reacted with pro- 
teinases. Further, when ol,M was mixed with inactivated 
chymotrypsin in the stoppedflow apparatus, the ob- 
served R, value was consistent with the estimated value 
for time zero. It was also confirmed that no further 
change was observed in stoppedflow experiments when 
the full scales of time were expanded to 100 s. 
The gross conformational change of a,M during the 
trapping of proteinase was shown to follow a single ex- 
ponential first-order reaction. This proved that the rate 
of conformational change was not limited by the encoun- 
ter of proteinase but by one of the first-order reactions 
following the encounter, including the conformational 
change itself. This rate of the limiting step may corre- 
spond to k, proposed by Strickland et al. [13]. This 
means that the slower half of the TNS (6-(p-toluidino)-2- 
naphthalenesulfonic acid) fluorescence increase had cor- 
responded to the gross conformational change. 
The rate constants for chymotrypsin and trypsin 
seemed to be different, which suggests the existence of a 
reaction step that is not rate limited by the proteinase 
encounter but is still proteinase dependent. This pro- 
teinase-dependent rate-limiting step may or may not be 
the cleavage of the bait region. Recently we measured the 
rate of bait region cleavage using SDS-PAGE [25] and 
pH-indicating dye (in preparation), which showed the 
existence of cleavage that was faster than the rate shown 
here. These results suggest hat the cleavage of a second 
bait-region or an unknown proteinase-dependent reac- 
tion following bait region cleavage is the rate-limiting 
step for the conformational change rather than the first 
bait region cleavage. 
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The cleavage of a peptide bond by serine proteinase 
occurs in two steps: first is the acylation of the enzyme 
and second is the deacylation of the enzyme. As pro- 
teinase leaves the carboxyl-terminal of the cleaved pep- 
tide bond at the deacylation step, a,M has to trap pro- 
teinase before deacylation, which was estimated to be 
around 30 SC’ for the first bait region cleavage from the 
result mentioned above. The observed conformational 
change seems to be much slower than the first bait region 
cleavage, although the proteinase that cleaves the bait 
region rarely escapes from a,M. The gross conforma- 
tional change may not be the trapping action but rather 
may be the appearance of a recognition site for e.g. a 
receptor. Otherwise there may exist some mechanism to 
prohibit the escape of proteinase resulting in the cleavage 
of the second bait region, thus gaining time for a,M to 
undergo the gross conformational change. More experi- 
ments, including direct measurement of deacylation, are 
necessary to come to a conclusion about this. 
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